Victoria Socha

DocwireNews

Boston&mdash;There are few available data on how patterns of end-of-life care for patients with advanced chronic kidney disease (CKD) who opt to forgo maintenance dialysis are shaped by prior care from a nephrologist. Susan Wong, MD, MS, and colleagues at the US Veterans Administration (VA) Puget Sound Health Care System, Seattle, Washington, conducted an analysis of data on patients who did not pursue maintenance dialysis prior to death. The researchers reported results of the analysis during a poster session at the NKF Spring Clinical Meetings in a poster titled Nephrology Care in Patients with Advanced Kidney Disease Not Treated with Maintenance Dialysis.The case series included 812 patients in the VA healthcare system between 2000 and 2011 with advanced CKD who did not pursue maintenance dialysis prior to death. The researchers compared differences in patterns of end-of-life care among patients with advanced CKD (estimated glomerular filtration rate [eGFR], &lt;15 mL/min/1.73 m2) who had no nephrology clinic visits, those who had fewer than four nephrology clinic visits, and those who had four or more nephrology clinic visits during the year prior to cohort entry.Of the total cohort, 46.8% had no visits to the nephrology clinic, 35.1% had fewer than four visits, and 18.1% had four plus visits. Median time from cohort entry to death for patients who had no nephrology clinic visits was 96 days, compared with 250 days for those who had fewer than four visits and 273 days for those who had four or more visits. Compared with the patients who had no visits to the nephrology clinic, those with four plus visits were more likely to have received a palliative care consultation (66.0% vs 47.1%; odds ratio [OR], 1.76; 95% confidence interval [CI], 1.15-2.7) and be enrolled in hospice care (54.4% vs 31.1%; OR, 2.16; 95% CI, 1.423-3.30) prior to death.There were no differences in the proportion of patients who were hospitalized or had received an intensive procedure during the final month of&nbsp; life and had died in a hospital setting. Differences in time for cohort entry to death and rates of hospice enrollment between groups were attenuated in sensitivity analyses and were no longer statistically significant among patients with more rapid decline in eGFR (&gt;1 mL/min/1.73 m2).In summary, the researchers said, &ldquo;Receipt of more nephrology care was associated with a longer time between eGFR &lt;15 mL/min/1.73 m2 to death and more frequent receipt of supportive care services such as palliative care and hospice, but not in patients with more rapid progression of their CKD. Our findings suggest potential value in initiating advance care planning and active nephrology management upstream in the illness trajectory of patients who are considering not undergoing dialysis.&rdquo;Source: Wong S, O&rsquo;Hare A, Hebert P, Liu C-F. Nephrology care in patients with advanced kidney disease not treated with maintenance dialysis. Abstract of a poster presented at the National Kidney Foundation 2019 Spring Clinical Meetings, May 8-12, 2019, Boston, Massachusetts.

Jordana Jampel

Brensocatib Shows Positive Results for Managing Bronchiectasis Symptoms

Pulmonology

Areef Ishani, MD

Joel M. Topf, MD, FACP

Kidney Stones With Chlorthalidone Versus Hydrochlorothiazide

NKF Spring Clinical Meetings 2025

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Latest News

Nephrology Care for Patients with Advanced CKD Not Undergoing Dialysis

Chronic Kidney Disease

There are few available data on how patterns of end-of-life care for patients with advanced chronic kidney disease (CKD) who opt to forgo maintenance dialysis 

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe